NASC (Nascent Pharma Holdings) Change In Inventory: $0.80 Mil (TTM As of Sep. 2024)


NASC Nascent Pharma Holdings Inc NASC
12 GF Score
Price $0.01
View Full Analysis

What is Nascent Pharma Holdings Change In Inventory?

Nascent Pharma Holdings NASC -0.03% 12 Change In Inventory is $0.80 Mil as of Sep. 2024. GuruFocus rates NASC with a GF Score™ of 12/100.

Nascent Pharma Holdings's change in inventory for the quarter that ended in Sep. 2024 was $0.41 Mil. It means Nascent Pharma Holdings's inventory declined by $0.41 Mil from Jun. 2024 to Sep. 2024 .

Nascent Pharma Holdings's change in inventory for the fiscal year that ended in Dec. 2023 was $0.58 Mil. It means Nascent Pharma Holdings's inventory declined by $0.58 Mil from Dec. 2022 to Dec. 2023 .

Nascent Pharma Holdings's Total Inventories for the quarter that ended in Sep. 2024 was $0.16 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Nascent Pharma Holdings's Days Inventory for the quarter that ended in Sep. 2024 was 78.86.

Inventory Turnover measures how fast the company turns over its inventory within a year. Nascent Pharma Holdings's Inventory Turnover for the quarter that ended in Sep. 2024 was 1.16.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Nascent Pharma Holdings's Inventory-to-Revenue for the quarter that ended in Sep. 2024 was 23.97.

Nascent Pharma Holdings  (OTCPK:NASC) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Nascent Pharma Holdings's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=0.3595/0.416*365 / 4
=78.86

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Nascent Pharma Holdings's Inventory Turnover for the quarter that ended in Sep. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=0.416 / 0.3595
=1.16

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Nascent Pharma Holdings's Inventory to Revenue for the quarter that ended in Sep. 2024 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=0.3595 / 0.015
=23.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nascent Pharma Holdings Change In Inventory Related Terms

Nascent Pharma Holdings Change In Inventory Historical Data

* Premium members only.

The historical data trend for Nascent Pharma Holdings's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nascent Pharma Holdings Change In Inventory Chart

Nascent Pharma Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.21 0.93 -2.21 0.53 0.58

Nascent Pharma Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.77 -0.66 1.03 0.03 0.41
NASC
12GF Score
Nascent Pharma Holdings Inc NASC
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nascent Pharma Holdings Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of $0.80 Mil mean?
Nascent Pharma Holdings (NASC) has a Change In Inventory of $0.80 Mil as of Sep. 2024. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Nascent Pharma Holdings and its competitors.
Is Nascent Pharma Holdings' Change In Inventory too high?
Nascent Pharma Holdings' current Change In Inventory is $0.80 Mil. Overall, Nascent Pharma Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Nascent Pharma Holdings' Change In Inventory compare to ALID and CPMD?
Nascent Pharma Holdings' Change In Inventory of $0.80 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Drug Manufacturers company?
A good Change In Inventory depends on the Drug Manufacturers industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Nascent Pharma Holdings and its competitors. Nascent Pharma Holdings's current Change In Inventory is $0.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nascent Pharma Holdings stock overvalued right now?
Nascent Pharma Holdings (NASC) has a current Change In Inventory of $0.80 Mil. The current Change In Inventory is $0.80 Mil. Nascent Pharma Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Nascent Pharma Holdings (NASC), the current Change In Inventory is $0.80 Mil as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nascent Pharma Holdings Business Description

Address 44 East End Avenue, Hicksville, NY, USA, 11801
Nascent Pharma Holdings Inc has acquired a Subsidiary engaged in enforcing and commercializing the patents held by Nascent. The acquired patents cover liquid formulations of cannabis. The patents relate to the extraction of pharmaceutically active components from plant materials, and more particularly to the preparation of a botanical drug substance for incorporation into a medicament and for use in pharmaceutical formulations, in particular comprising cannabinoids obtained from cannabis. Patented uses include using the liquid formulations to alleviate numerous debilitating conditions, including cancer, irritable bowel syndrome, chronic pain, post-traumatic stress disorder, anxiety, sleep disorders, and opioid dependencies.
12GF Score

Get the complete analysis for NASC

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01
Price